Biogen Inc (BIIB) A Step Ahead To Treat SMA - - TCC
The approval of the drug will bring a new window of opportunity for the companies, both geographically and therapeutically Biogen Inc (NASDAQ:BIIB) and Ionis have been filling their mutual investigational molecule nusinersen for the New Drug Application (NDA) to the Food and Drug Administration (FDA). The molecule is indicated for the management and treatment of